GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company that combines both individual talent and technical resources to create a platform for the delivery of strong growth in a rapidly changing healthcare market. Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
Our Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation and oncology. We are strengthening our R&D pipeline through a focus on immunology, human genetics and advanced technologies to help us deliver transformational new medicines for patients.
We are currently recruiting for a Health Economist on a full time, permanent basis. As the Health Economist for GSK Ireland, you will be the health economics and outcomes research (HEOR) expert and skills resource for the GSK Ireland business with responsibility for completion of pharmaco-economic (PE) submissions (rapid reviews and HTA) for the innovative GSK and ViiV medicines’ portfolio. You will also lead on HEOR technical documents and/or research projects to maintain and grow the publicly and privately funded vaccine business.
In this role you will…
Provide the HEOR expertise for all NCPE pharmaco-economic submissions (rapid review [RR] and full-HTA) for new innovation medicines and indication extensions (in all therapy areas including oncology, respiratory, HIV therapies and others), and lead on HEOR technical documents and/or research projects for the vaccines business.
Assume the role of project manager and lead author for all sections of the PE dossiers (RR/HTA) to ultimately secure timely patient access to new GSK and ViiV medicines (reporting to the Head of Market Access and supported by the Medical Affairs team for clinical and epidemiology sections).
Responsible for defining the appropriate clinical profiles, relevant comparators and evidence generation needed for delivering robust HTA submissions for the innovation portfolio in line with the commercial strategy of GSK Ireland. Work with the medical affairs team to identify and include all necessary clinical data and scientific publications required for the HTA dossier.
Accountable and responsible for gathering the relevant epidemiological, clinical, comparator and ancillary cost of treatment data/inputs required for the production and completion of pharmaco-economic and budget impact analyses for PE dossiers.
Responsible for building the final cost-effectiveness model(s) appropriate for the Irish healthcare setting using the reference global cost-effectiveness model. Must be proficient to complete all modifications required for compatibility with the requirements of the NCPE.
Responsible for all health outcomes (HO) data generation, HO studies and publications relating to existing and new GSK and ViiV medicines to support the clinical and economic value proposition in commercial negotiations with the payor to secure the ambition for speed and breadth of access for Irish patients to these innovative medicines.
Engage and partner with the commercial brand and/or medical teams (and any other relevant internal stakeholder) to provide HEOR expertise and skills for health technology assessment and health technology management projects pre- and post-pricing and reimbursement to achieve the best launch trajectory for the new innovation.
Initiating and maintaining all necessary and appropriate contacts with NCPE, HSE, HIQA, Advisory Bodies, other Government Officials, External Experts, Universities, and related relevant institutes and bodies in order to optimise execution of the above-mentioned tasks, while focusing on the primary responsibility of the timely and accurate completion of robust HTA dossiers for pharmaco-economic assessment by the NCPE.
Live the values, principles and expectations of GSK; always act and behave within all ethical, legal and compliance codes of industry and GSK, while delivering timely, robust, value-added and high-quality results for the business.
The list of responsibilities is not exhaustive and may be subject to amendment depending on the requirements of the business.
We are looking for professionals with these required skills to achieve our goals:
Bachelor's degree in relevant science, engineering or business area with master's qualification in health economics.
Extensive experience working in the Irish pharmaceutical and/or healthcare environment and experience working in the core competency area of pharmaceutical economics and/or health economics.
Experience of working for and/or engaging with Irish HTA agencies is essential.
Expert working knowledge in pharmaceutical and/or health economics modelling and budget impact analyses, outcome research methodology, quality of life measurement and cost data identification for use in the health technology assessment in the target therapeutic areas.
Knowledge and working understanding of the national guidelines in economic evaluation, including the Guidelines for the Economic Evaluation of Health Technologies in Ireland (2019) and Guidelines for the Budget Impact Analysis of Health Technologies in Ireland (2018), along with the Health (Pricing and Supply of Medical Goods) Act 2013.
Experience with NCPE processes, HSE value propositions, evidence generation for HTA dossiers and pricing and reimbursement strategies successfully implemented with the HSE.
Experience of medical writing and/or track record of scientific publications is advantageous.
Working knowledge about the current and planned future developments in the Irish healthcare system, along with the rules, agreements (e.g. IPHA) and regulations specific to HTA and the pricing and reimbursement of medicines in Ireland.
Purpose and performance driven individual with excellent analytical and improvisation skills.
Preferred Qualifications/ Experience
If you have the following characteristics, it would be a plus:
Qualified pharmacist or medical doctor with master's and/or PhD qualification in health economics.
Health economics work experience for HTA submissions in the oncology therapy area.
At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we’re making the most significant changes we’ve made to our business in over 20 years. We’re on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science; and a new world-leading consumer healthcare company of loved and trusted brands.
With new ambition comes new purpose. For New GSK, this is to unite science, talent, and technology to get ahead of disease together – all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive.
Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients – so we deliver what matters better and faster; accountable for impact – with clear ownership of goals and support to succeed; and where we do the right thing. So, if you’re ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together.
Como empresa impulsada por nuestros valores de enfoque al paciente, transparencia, respeto e integridad, sabemos que la inclusión y la diversidad son esenciales para que podamos tener éxito. Queremos que todos nuestros colegas prosperen en GSK, brindando sus experiencias únicas, asegurándonos de que se sientan bien y que sigan creciendo en sus carreras. Como candidato para un papel, queremos que usted se sienta de la misma manera.
Creemos en una cultura de trabajo ágil para todos nuestros roles. Si la flexibilidad es importante para usted, lo alentamos a explorar con nuestro equipo de contratación cuáles son las oportunidades.
No dude en ponerse en contacto con nosotros si desea analizar cualquier ajuste a nuestro proceso que pueda ayudarlo a demostrar sus fortalezas y capacidades. Puede llamarnos al 0[Register to View] o enviar un correo electrónico [Register to View] [Register to View]
A medida que lo solicite, le pediremos que comparta alguna información personal que sea voluntaria. Esto se utilizará para ayudarnos a comprender qué tan bien estamos haciendo frente a nuestras ambiciones de inclusión y diversidad. Realmente lo agradeceríamos si pudiera tomarse unos momentos para completarlo. Tenga la seguridad de que los gerentes de contratación no tienen acceso a esta información, no se utiliza en ninguna parte del proceso de selección y trataremos su información de forma confidencial y la utilizaremos de forma anónima.